Genetic characterisation of drug-resistant Mycobacterium tuberculosis in rural China: A population-based study

International Journal of Tuberculosis and Lung Disease

Volumn 14, Issue 2, 2010, Pages 210-216

  Hu, Y ^a   Hoffner, S ^b   Jiang, W ^a   Wang, W ^a   Xu, B ^a  

^a FUDAN UNIVERSITY   (China)

^b SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

Author keywords

Drug resistance; Genetic mutation; Mycobacterium tuberculosis

Indexed keywords

ETHAMBUTOL; ISONIAZID; RIFAMPICIN; STREPTOMYCIN;

AMINO ACID SUBSTITUTION; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL MUTATION; BACTERIAL STRAIN; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CHINA; CHINESE; CODON; DNA SEQUENCE; DRUG RESISTANT TUBERCULOSIS; GENE MUTATION; GENETIC TRAIT; GENOTYPE PHENOTYPE CORRELATION; HEALTH PROGRAM; HUMAN; MAJOR CLINICAL STUDY; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PREDICTION; PRIORITY JOURNAL; RURAL AREA;

ANTITUBERCULAR AGENTS; BACTERIAL PROTEINS; CHINA; CODON; DIRECTLY OBSERVED THERAPY; GENOTYPE; HUMANS; ISONIAZID; MICROBIAL SENSITIVITY TESTS; MUTATION; MYCOBACTERIUM TUBERCULOSIS; PHENOTYPE; RIFAMPIN; RURAL POPULATION; SEQUENCE ANALYSIS, DNA; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 77049126228     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Cohn D L, Bustreo F, Raviglione M C. Drug-resistant tuberculosis: review of the worldwide situation and the World Health Organization/International Union Against Tuberculosis and Lung Disease Global Surveillance Project. Clin Infect Dis 1997; 24 (Suppl 1): S121-S130.
2. Zignol M, Hosseini M S, Wright A, et al. Global incidence of multidrug-resistant tuberculosis. J Infect Dis 2006; 194: 479-485.
3. Ministry of Health, China. Report on nationwide random survey for the epidemiology of tuberculosis in 2000. J Chinese Anti-tuberculosis Assoc 2002; 24: 65-108.
4. Garcia de Viedma D. Rapid detection of resistance in Mycobacterium tuberculosis: a review discussing molecular approaches. Clin Microbiol Infect 2003; 9: 349-359.
5. Ramaswamy S, Musser J M. Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. Tubercle Lung Dis 1998; 79: 3-29.
6. Hu Y, Mathema B, Wang W, Hoffner S, Kreiswirth B, Xu B. Prevalence of multidrug-resistant pulmonary tuberculosis in counties with different duration of DOTS implementation in rural China. Microb Drug Resist 2008; 14: 227-232.
7. World Health Organization/International Union Against Tuberculosis and Lung Disease Global Working Group on Anti-shy; tuberculosis Drug Resistance Surveillance. Guidelines for surveillance of drug resistance in tuberculosis. Int J Tuberc Lung Dis 1998; 2: 72-89.
8. Chen X, Ma Y, Jin Q, et al. [Characterization of the katG, inhA, ahpC, kasA and oxyR gene mutations in isoniazid-resistant and susceptible strain of Mycobacterium tuberculosis by automated DNA sequencing]. Zhonghua Jie He He Hu Xi Za Zhi 2005; 28: 250-253. [Chinese]
9. Katsukawa C, Tamaru A, Miyata Y, Abe C, Makino M, Suzuki Y. Characterization of the rpsL and rrs genes of streptomycin- resistant clinical isolates of Mycobacterium tuberculosis in Japan. J Appl Microbiol 1997; 83: 634-640.
10. Rouse D A, DeVito J A, Li Z, Byer H, Morris S L. Site-directed mutagenesis of the katG gene of Mycobacterium tuberculosis: effects on catalase-peroxidase activities and isoniazid resistance. Mol Microbiol 1996; 22: 583-592.
11. van Soolingen D, de Haas P E, van Doorn H R, Kuijper E, Rinder H, Borgdorff M W. Mutations at amino acid position 315 of the katG gene are associated with high-level resistance to isoniazid, other drug resistance, and successful transmission of Mycobacterium tuberculosis in the Netherlands. J Infect Dis 2000; 182: 1788-1790.
12. Ramaswamy S V, Dou S J, Rendon A, Yang Z, Cave M D, Graviss E A. Genotypic analysis of multidrug-resistant Mycobacterium tuberculosis isolates from Monterrey, Mexico. J Med Microbiol 2004; 53: 107-113.
13. Mokrousov I, Otten T, Vyshnevskiy B, Narvskaya O. Allele-specific rpoB PCR assays for detection of rifampin-resistant Mycobacterium tuberculosis in sputum smears. Antimicrob Agents Chemother 2003; 47: 2231-2235.
14. Lipin M Y, Stepanshina V N, Shemyakin I G, Shinnick T M. Association of specific mutations in katG, rpoB, rpsL and rrs genes with spoligotypes of multidrug-resistant Mycobacterium tuberculosis isolates in Russia. Clin Microbiol Infect 2007; 13: 620-626.
15. Shi R, Zhang J, Li C, Kazumi Y, Sugawara I. Detection of streptomycin resistance in Mycobacterium tuberculosis clinical isolates from China as determined by denaturing HPLC analysis and DNA sequencing. Microbes Infect 2007; 9: 1538-1544.
16. Sreevatsan S, Pan X, Stockbauer K E, Williams D L, Kreiswirth B N, Musser J M. Characterization of rpsL and rrs mutations in streptomycin-resistant Mycobacterium tuberculosis isolates from diverse geographic localities. Antimicrob Agents Chemother 1996; 40: 1024-1026.
17. Telenti A, Philipp W J, Sreevatsan S, et al. The emb operon, a gene cluster of Mycobacterium tuberculosis involved in resistance to ethambutol. Nat Med 1997; 3: 567-570.
18. Lee A S, Othman S N, Ho Y M, Wong S Y. Novel mutations within the embB gene in ethambutol-susceptible clinical isolates of Mycobacterium tuberculosis. Antimicrob Agents Chemother 2004; 48: 4447-4449.
19. Sreevatsan S, Stockbauer K E, Pan X, et al. Ethambutol resistance in Mycobacterium tuberculosis: critical role of embB mutations. Antimicrob Agents Chemother 1997; 41: 1677-1681.
20. Ramaswamy S V, Amin A G, Goksel S, et al. Molecular genetic analysis of nucleotide polymorphisms associated with ethambutol resistance in human isolates of Mycobacterium tubercu losis. Antimicrob Agents Chemother 2000; 44: 326-336.
21. Parsons L M, Salfinger M, Clobridge A, et al. Phenotypic and molecular characterization of Mycobacterium tuberculosis isolates resistant to both isoniazid and ethambutol. Antimicrob Agents Chemother 2005; 49: 2218-2225.
22. Tracevska T, Jansone I, Nodieva A, Marga O, Skenders G, Baumanis V. Characterisation of rpsL, rrs and embB mutations associated with streptomycin and ethambutol resistance in Mycobacterium tuberculosis. Res Microbiol 2004; 155: 830-834.
23. Hazbon M H, Bobadilla del Valle M, Guerrero M I, et al. Role of embB codon 306 mutations in Mycobacterium tuberculosis revisited: a novel association with broad drug resistance and IS6110 clustering rather than ethambutol resistance. Antimicrob Agents Chemother 2005; 49: 3794-3802.
24. Ahmad S, Fares E. Genotypic diversity among isoniazid-resistant isolates of Mycobacterium tuberculosis from Rashid hospital in Dubai, United Arab Emirates. Med Princ Pract 2005; 14: 16-21.
25. Cardoso R F, Cooksey R C, Morlock G P, et al. Screening and characterization of mutations in isoniazid-resistant Mycobacterium tuberculosis isolates obtained in Brazil. Antimicrob Agents Chemother 2004; 48: 3373-3381.
26. Zhang M, Yue J, Yang Y P, et al. Detection of mutations associated with isoniazid resistance in Mycobacterium tuberculosis isolates from China. J Clin Microbiol 2005; 43: 5477-5482.
27. Initial therapy for tuberculosis in the era of multidrug resistance. Recommendations of the advisory council for the elimination of tuberculosis. MMWR Recomm Rep 1993; 42 (RR-7): 1-8.
28. Suresh N, Singh U B, Arora J, et al. rpoB gene sequencing and spoligotyping of multidrug-resistant Mycobacterium tuberculosis isolates from India. Infect Genet Evol 2006; 6: 474-483.
29. Sintchenko N, Chew W K, Jelfs P J, et al. Mutations in rpoB gene and rifabutin susceptibility of multidrug-resistant Mycobacterium tuberculosis trains isolated in Australia. Pathology 1999; 31: 257-260.